Monoclonal gammopathy detection and current technologies Book Section


Authors: Hutcherson, S. M.; Thoren, K. L.
Editors: Ramanathan, L. V.; Fleisher, M.; Duffy, M. J.
Article/Chapter Title: Monoclonal gammopathy detection and current technologies
Title Series: Clinical Aspects and Laboratory Determination
Abstract: Monoclonal gammopathies are characterized by the abnormal proliferation of a single clone of B lymphocytes, usually a plasma cell, which often results in the excess production of a monoclonal immunoglobulin (M-protein). The M-protein is an important part of the diagnosis and management of patients with monoclonal gammopathies. Protein electrophoresis and immunofixation have provided a simple and effective way to detect, quantitate and identify M-proteins in serum and urine for decades. However, improvements in the treatment of multiple myeloma are now driving the development of more sensitive and specific laboratory tests. In this chapter, we review the different monoclonal gammopathies, discuss the current electrophoretic techniques, and discuss new approaches that are being developed to detect the M-protein. © 2022 Elsevier Inc. All rights reserved.
Keywords: mass spectrometry; multiple myeloma; electrophoresis; immunofixation; monoclonal gammopathy; m-protein
Book Title: Cancer Biomarkers: Clinical Aspects and Laboratory Determination
ISBN: 978-0-12-824302-2
Publisher: Elsevier Inc.  
Publication Place: Amsterdam, Netherlands
Date Published: 2022-01-01
Start Page: 173
End Page: 201
Language: English
DOI: 10.1016/b978-0-12-824302-2.00005-9
PROVIDER: scopus
DOI/URL:
Notes: Book Chapter: 6; This is the 5th volume in Clinical Aspects and Laboratory Determination -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Katie Lynn Thoren
    37 Thoren